Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$285,122
-$18,355 QoQ
Shares Held
2,412
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $2,556,716 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,394 | $755,311 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,229 | $544,215 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,383 | $403,185 | |
| 4 | ALKS |
Alkermes plc.
|
4,793 | $251,153 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
2,186 | $242,514 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
6,782 | $235,131 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
25,397 | $125,207 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $285,122 | 2,412 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $303,477 | 2,412 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $352,923 | 2,412 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $388,003 | 2,488 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $419,857 | 2,550 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $424,758 | 2,607 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $517,952 | 2,651 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $513,145 | 2,960 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $551,624 | 3,260 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $761,848 | 3,860 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $698,529 | 4,015 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $691,423 | 4,015 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $668,256 | 4,015 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $440,675 | 3,007 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $549,711 | 3,707 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $637,196 | 3,707 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $623,667 | 3,307 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $758,201 | 3,107 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $594,844 | 3,064 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $571,007 | 3,064 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $482,518 | 3,064 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $519,173 | 3,137 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,244,055 | 25,664 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $448,943 | 3,276 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $396,850 | 3,372 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||